18 December 2019

KWM releases Special Issue for the New Drug Administration Law (Chinese)

On August 26, 2019, the newly revised Drug Administration Law (“New Law”) was officially issued. The promulgation of the New Law has established a new legal regulatory framework, resulted in significant changes for the pharmaceutical and healthcare industry, and promoted international integration. Given its implications for current and future market participants, timely interpretation of the law is required by local and foreign companies operating in the Chinese healthcare sector.

KWM Insights: Special Issue for the New Drug Administration Law was co-published by King & Wood Mallesons and KWM Institute. Nearly 20 partners who specialize in pharmaceutical and healthcare law, provided their insights covering a broad range of topics relating to the New Law, including drug marketing authorization holder system, online sales of prescription drugs, clinical trials, regulations on imported drugs, and liability for fake and inferior medicines.

Chinese Only


Share on LinkedIn Share on Facebook Share on Twitter
    You might also be interested in

    We sum up the definitions of accredited investor and qualified institutional buyer as proposed by the U.S. Securities and Exchange Commission.

    10 September 2020

    The Bureau of Industry and Security (BIS) within the US Department of Commerce has announced in an Advance Notice of Proposed Rulemaking that it is seeking public comments on how it should define and...

    01 September 2020

    On January 17, 2020, the PRC Ministry of Finance and State Administration of Taxation jointly issued the Announcement on Individual Income Tax Policies Relating to Foreign Income (关于境外所得有关个人所得税政策的公告)...

    17 August 2020

    On 20 July 2020, the Accounting and Corporate Regulatory Authority (ACRA) of Singapore published the report of the Companies Act Working Group (CAWG) (Report).

    11 August 2020

    This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

    For more information on which cookies we use then please refer to our Cookie Policy.